Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carcinoma, Squamous Cell/chemically induced"'
Autor:
Na Sun, Sabina Berezowska, Maximilian Ackermann, Michaela Aichler, Isis E. Fernandez, Ralph A. Schmid, Oliver Eickelberg, Marco Matzka, Axel Walch, Thomas Kunzke, Wim A. Wuyts, Annette Feuchtinger, Verena M. Prade, Danny Jonigk, Achim Buck
Publikováno v:
Cancer research, vol. 81, no. 23, pp. 5862-5875
Asymptomatic anthracosis is the accumulation of black carbon particles in adult human lungs. It is a common occurrence, but the pathophysiologic significance of anthracosis is debatable. Using in situ high mass resolution matrix-assisted laser desorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7102791f2db44bef049fe753a08f16
https://serval.unil.ch/notice/serval:BIB_10B46795FCEE
https://serval.unil.ch/notice/serval:BIB_10B46795FCEE
Autor:
Sam Polesie, Martin Gillstedt, Sigrún Alba Jóhannesdóttir Schmidt, Alexander Egeberg, Anton Pottegård, Kasper Kristensen
Publikováno v:
Polesie, S, Gillstedt, M, Schmidt, S A J, Egeberg, A, Pottegard, A & Kristensen, K B 2020, ' Use of methotrexate and risk of skin cancer: A nationwide case-control study ', Pharmacoepidemiology and Drug Safety, vol. 29, no. Suppl. 3, 3965, pp. 463 . < https://doi.org/10.1002/pds.5114 >
University of Southern Denmark
Polesie, S, Gillstedt, M, Schmidt, S A J, Egeberg, A, Pottegård, A & Kristensen, K 2023, ' Use of methotrexate and risk of skin cancer : a nationwide case-control study ', British Journal of Cancer, vol. 128, no. 7, pp. 1311-1319 . https://doi.org/10.1038/s41416-023-02172-7
University of Southern Denmark
Polesie, S, Gillstedt, M, Schmidt, S A J, Egeberg, A, Pottegård, A & Kristensen, K 2023, ' Use of methotrexate and risk of skin cancer : a nationwide case-control study ', British Journal of Cancer, vol. 128, no. 7, pp. 1311-1319 . https://doi.org/10.1038/s41416-023-02172-7
Background Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the association between the use of MTX and the risk of basal cell carcinoma (BCC), cutaneous squamous cell carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe8b603470a2a20d40f9e9a7b096078a
https://portal.findresearcher.sdu.dk/da/publications/bbaa4389-a76d-425d-8139-d708b71a92d5
https://portal.findresearcher.sdu.dk/da/publications/bbaa4389-a76d-425d-8139-d708b71a92d5
Autor:
Søren Friis, Anton Pottegård, Sigrún Alba Jóhannesdóttir Schmidt, Lisbet Rosenkrantz Hölmich, David Gaist, Sidsel Arnspang Pedersen
Publikováno v:
Arnspang, S, Gaist, D, Johannesdottir Schmidt, S A, Hölmich, L R, Friis, S & Pottegård, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, pp. 673-681.e9 . https://doi.org/10.1016/j.jaad.2017.11.042
Pedersen, S A, Gaist, D, Schmidt, S A J, Hölmich, L R, Friis, S & Pottegård, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, pp. 673-681.e9 . https://doi.org/10.1016/j.jaad.2017.11.042
Pedersen, S A, Gaist, D, Schmidt, S A J, Holmich, L R, Friis, S & Pottegard, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, e9, pp. 673-681 . https://doi.org/10.1016/j.jaad.2017.11.042
Pedersen, S A, Gaist, D, Schmidt, S A J, Hölmich, L R, Friis, S & Pottegård, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, pp. 673-681.e9 . https://doi.org/10.1016/j.jaad.2017.11.042
Pedersen, S A, Gaist, D, Schmidt, S A J, Holmich, L R, Friis, S & Pottegard, A 2018, ' Hydrochlorothiazide use and risk of nonmelanoma skin cancer : A nationwide case-control study from Denmark ', Journal of the American Academy of Dermatology, vol. 78, no. 4, e9, pp. 673-681 . https://doi.org/10.1016/j.jaad.2017.11.042
Background: Hydrochlorothiazide, one of the most frequently used diuretic and antihypertensive drugs in the United States and Western Europe, is photosensitizing and has previously been linked to lip cancer. Objective: To examine the association betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a578e3c2877b5f4ae48af119a4838ecf
https://findresearcher.sdu.dk:8443/ws/files/137606525/Hydrochlorothiazide_use_and_risk_of_non_melanoma_skin_cancer.pdf
https://findresearcher.sdu.dk:8443/ws/files/137606525/Hydrochlorothiazide_use_and_risk_of_non_melanoma_skin_cancer.pdf
Autor:
Søren Friis, Gary D. Friedman, Anton Pottegård, Laurel A. Habel, Mathias Tiedemann Svendsen, Jesper Hallas, Morten Olesen
Publikováno v:
Pottegård, A, Hallas, J, Olesen, M, Svendsen, M T, Habel, L A, Friedman, G D & Friis, S 2017, ' Hydrochlorothiazide use is strongly associated with risk of lip cancer ', Journal of Internal Medicine, vol. 282, no. 4, pp. 322-331 . https://doi.org/10.1111/joim.12629
SummaryBackground The diuretic hydrochlorothiazide is among the most frequently prescribed drugs in the United States and Western Europe, but there is suggestive evidence that hydrochlorothiazide use increases the risk of lip cancer. Objectives To st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85751efb4407fa546263f6b9406fd83f
https://pubmed.ncbi.nlm.nih.gov/28480532
https://pubmed.ncbi.nlm.nih.gov/28480532
Publikováno v:
British Journal of Cancer
British journal of cancer, vol. 89, no. 12, pp. 2320-2326
British journal of cancer, vol. 89, no. 12, pp. 2320-2326
The response to photodynamic therapy (PDT) with the photosensitiser (PS) Tookad was measured in the Syrian hamster cheek pouch model on normal mucosae and chemically induced squamous cell carcinoma. This PS is a palladium-bacteriopheophorbide present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aed88d5f661db9cbd1eacb55d67efd3
http://europepmc.org/articles/PMC2395293
http://europepmc.org/articles/PMC2395293
Autor:
Piotr Dziunycz, Karine Lefort, Xunwei Wu, G. Paolo Dotto, Sungeun Chang, Bach-Cuc Nguyen, Yang Sui Brooks, Günther F.L. Hofbauer
Publikováno v:
Nature
Nature, vol. 465, no. 7296, pp. 368-372
Nature, vol. 465, no. 7296, pp. 368-372
Calcineurin inhibitors such as cyclosporin A (CsA) are the mainstay of immunosuppressive treatment for organ transplant recipients. Squamous cell carcinoma (SCC) of the skin is a major complication of treatment with these drugs, with a 65 to 100-fold
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c401cd0f52ac396b891110f36c4b6f36
https://doi.org/10.5167/uzh-41832
https://doi.org/10.5167/uzh-41832